Chemomab Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMMB and other ETFs, options, and stocks.

About CMMB

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. 

CEO
Dale R. Pfost
CEODale R. Pfost
Employees
—
Employees—
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2011
Founded2011
Employees
—
Employees—

CMMB Key Statistics

Market cap
24.50M
Market cap24.50M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
23.94K
Average volume23.94K
High today
$2.24
High today$2.24
Low today
$2.09
Low today$2.09
Open price
$2.13
Open price$2.13
Volume
29.26K
Volume29.26K
52 Week high
$8.76
52 Week high$8.76
52 Week low
$1.75
52 Week low$1.75

CMMB Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Estimated— per share
Actual
Expected Mar 8, Pre-Market
ActualExpected Mar 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.